Treatment with PTEN mRNA-NPs significantly promoted cancer cell apoptosis by inhibiting the PI3K/Akt pathway, and the therapeutic effect was verified in a mouse model of prostate cancer (PCa) xenograft [159]. The gene discussed is PTEN; the disease is cancer.